P01 CA66726/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	3
1999	1
2000	2
2001	2
2002	1
2005	2
2007	1
2010	2
2011	4
2012	2
2013	1
2024	0

1

Vachani A, Moon E, Wakeam E, Haas AR, Sterman DH, Albelda SM. Vachani A, et al. Clin Chest Med. 2011 Dec;32(4):865-85. doi: 10.1016/j.ccm.2011.08.006. Epub 2011 Oct 7. Clin Chest Med. 2011. PMID: 22054892 Free PMC article. Review.

2

Gene therapy for malignant pleural mesothelioma.

Sterman DH, Kaiser LR, Albelda SM. Sterman DH, et al. Hematol Oncol Clin North Am. 1998 Jun;12(3):553-68. doi: 10.1016/s0889-8588(05)70008-3. Hematol Oncol Clin North Am. 1998. PMID: 9684098 Free article. Review.

3

Gene therapy for malignant pleural mesothelioma.

Sterman DH. Sterman DH. Hematol Oncol Clin North Am. 2005 Dec;19(6):1147-73, viii. doi: 10.1016/j.hoc.2005.09.004. Hematol Oncol Clin North Am. 2005. PMID: 16325129 Review.

4

Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Tijono SM, Guo K, Henare K, Palmer BD, Wang LC, Albelda SM, Ching LM. Tijono SM, et al. Br J Cancer. 2013 Apr 2;108(6):1306-15. doi: 10.1038/bjc.2013.101. Epub 2013 Mar 12. Br J Cancer. 2013. PMID: 23481185 Free PMC article.

5

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.

Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Sinha P, et al. J Immunol. 2007 Jul 15;179(2):977-83. doi: 10.4049/jimmunol.179.2.977. J Immunol. 2007. PMID: 17617589

6

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.

Sterman DH, Haas A, Moon E, Recio A, Schwed D, Vachani A, Katz SI, Gillespie CT, Cheng G, Sun J, Papasavvas E, Montaner LJ, Heitjan DF, Litzky L, Friedberg J, Culligan M, June CH, Carroll RG, Albelda SM. Sterman DH, et al. Am J Respir Crit Care Med. 2011 Dec 15;184(12):1395-9. doi: 10.1164/rccm.201103-0554CR. Epub 2011 Jun 3. Am J Respir Crit Care Med. 2011. PMID: 21642245 Free PMC article. Clinical Trial.

7

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.

Predina JD, Kapoor V, Judy BF, Cheng G, Fridlender ZG, Albelda SM, Singhal S. Predina JD, et al. J Hematol Oncol. 2012 Jun 28;5:34. doi: 10.1186/1756-8722-5-34. J Hematol Oncol. 2012. PMID: 22742411 Free PMC article.

8

Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation.

Sun J, Wang LC, Fridlender ZG, Kapoor V, Cheng G, Ching LM, Albelda SM. Sun J, et al. Biochem Pharmacol. 2011 Nov 1;82(9):1175-85. doi: 10.1016/j.bcp.2011.07.086. Epub 2011 Jul 26. Biochem Pharmacol. 2011. PMID: 21819972 Free PMC article.

9

A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy.

Shiue GG, Shiue CY, Lee RL, MacDonald D, Hustinx R, Eck SL, Alavi AA. Shiue GG, et al. Nucl Med Biol. 2001 Oct;28(7):875-83. doi: 10.1016/s0969-8051(01)00253-0. Nucl Med Biol. 2001. PMID: 11578910

10

Potential applications of PET imaging in developing novel cancer therapies.

Hustinx R, Eck SL, Alavi A. Hustinx R, et al. J Nucl Med. 1999 Jun;40(6):995-1002. J Nucl Med. 1999. PMID: 10452317 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year